Publicaciones en colaboración con investigadores/as de Gustave Roussy Cancer Campus (4)

2021

  1. Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

    npj Breast Cancer, Vol. 7, Núm. 1

2018

  1. ERþ Breast cancers resistant to prolonged neoadjuvant letrozole exhibit an e2f4 transcriptional program sensitive to cdk4/6 inhibitors

    Clinical Cancer Research, Vol. 24, Núm. 11, pp. 2517-2529

2005

  1. The natural history of breast carcinoma in patients with ≥ 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: A multiinstitutional retrospective study

    Cancer, Vol. 104, Núm. 2, pp. 229-235

2003

  1. Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

    Annals of Oncology, Vol. 14, Núm. 8, pp. 1246-1252